Which has grown faster, ACHC or RXRX?

Over the past five years, RXRX grew revenue faster — ACHC at a 8.67% CAGR versus RXRX at 45.50%.

How have ACHC and RXRX total returns compared?

Over the past 5 years, ACHC delivered -13.91% and RXRX delivered -25.86% annualized total return. Past performance doesn't predict future results.

Acadia Healthcare Company, Inc. (ACHC) vs Recursion Pharmaceuticals, Inc. (RXRX)

A side-by-side comparison of Acadia Healthcare Company, Inc. and Recursion Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ACHC

Acadia Healthcare Company, Inc.

$2.69B

$28.87HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

RXRX

Recursion Pharmaceuticals, Inc.

$2.51B

$4.78HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — ACHC vs RXRX

growth of $100 · dividends reinvested · last 5y

ACHC -51.4% (-13.4%/yr)RXRX -73.4% (-23.3%/yr)ACHC compounded faster over this window

ACHC RXRX

ACHC vs RXRX: by the numbers

•ACHC is the larger company ($2.69B vs $2.51B market cap).
•Both run net losses; ACHC's is the smaller (-33.44% vs -945.92% net margin).
•RXRX grew revenue faster over the past five years (45.50% vs 8.67% CAGR).

Metrics side by side

Valuation

Metric	ACHC	RXRX
Forward P/E	18.92	N/A
P/S ratio	0.80	45.72
P/B ratio	1.36	2.74
EV / EBITDA	9.50	N/A

Profitability

Metric	ACHC	RXRX
Gross margin	17.61%	-61.96%
Operating margin	10.06%	-867.87%
Net margin	-33.44%	-945.92%
ROE	-56.91%	-56.71%
ROIC	6.69%	-49.78%

Growth (annualized)

Metric	ACHC	RXRX
Revenue CAGR (5Y)	8.67%	45.50%
Total return CAGR (5Y)	-13.91%	-25.86%

Frequently asked

Which has grown faster, ACHC or RXRX?: Over the past five years, RXRX grew revenue faster — ACHC at a 8.67% CAGR versus RXRX at 45.50%.
How have ACHC and RXRX total returns compared?: Over the past 5 years, ACHC delivered -13.91% and RXRX delivered -25.86% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ACHC analysis Full RXRX analysis Interactive comparison tool

Dig into the metrics

Acadia Healthcare ROE Recursion Pharmaceuticals ROE Acadia Healthcare operating margin Recursion Pharmaceuticals operating margin Acadia Healthcare revenue growth Recursion Pharmaceuticals revenue growth Acadia Healthcare free cash flow Recursion Pharmaceuticals free cash flow

Acadia Healthcare & Recursion Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.